Motoyuki Higa

Effect of Probiotic Bifidobacterium breve in Improving Cognitive Function and Preventing Brain Atrophy in Older Patients with Suspected Mild Cognitive Impairment: Results of a 24-Week Randomized, Double-Blind, Placebo-Controlled Trial

Daisuke Asaoka, Jin‐zhong Xiao, Tsutomu Takeda et al. · Journal of Alzheimer s Disease · 2022 · 133 citations · Full text

Significance of Measurements of Peripheral Carbonyl Stress Markers in a Cross-sectional and Longitudinal Study in Patients With Acute-stage Schizophrenia

Narimasa Katsuta, Tohru Ohnuma, Hitoshi Maeshima et al. · Schizophrenia Bulletin · 2014 · 39 citations · Full text

Carbonyl Stress, Psychiatry, Carbonyl Stress Markers +13

Association study between Disrupted-in-Schizophrenia-1 (DISC1) and Japanese patients with treatment-resistant schizophrenia (TRS)

Yuri Hotta, Tohru Ohnuma, Ryo Hanzawa et al. · Progress in Neuro-Psychopharmacology and Biological Psychiatry · 2011 · 29 citations

Psychiatry, Psychotic Disorder, Psychiatric Genetics +10

Altered serum glyceraldehyde-derived advanced glycation end product (AGE) and soluble AGE receptor levels indicate carbonyl stress in patients with schizophrenia

Mayu Takeda, Tohru Ohnuma, Masayoshi Takeuchi et al. · Neuroscience Letters · 2015 · 23 citations · Full text

No Correlation between Plasma NMDA-Related Glutamatergic Amino Acid Levels and Cognitive Function in Medicated Patients with Schizophrenia

Tohru Ohnuma, Yoshie Sakai, Hitoshi Maeshima et al. · The International Journal of Psychiatry in Medicine · 2012 · 15 citations